M&A Industry News
A collection of M&A latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
AstraZeneca in talks over £300bn mega-merger with US rival - reports
News from The City, market updates plus comment and analysis from our business desk I would like to be emailed about offers, event and updates from Evening Standard. Read our privacy notice. AstraZeneca has held talks with US rival Bristol Myers…
AstraZeneca in talks over £300bn mega-merger with US rival - reports
AstraZeneca has held talks with US rival Bristol Myers Squibb over a merger which could create a drugs giant worth more than £300 billion, according to reports. The two pharmaceutical firms have held discussions over a potential tie-up in…
AstraZeneca holds talks with Bristol Myers Squibb on $400bn merger
Britain's biggest drugmaker AstraZeneca is understood to be in discussions to take over its US rival Bristol Myers Squibb in a deal that would create a near-$400bn (£300bn) pharmaceutical group. AstraZeneca, run by Pascal Soriot, its longtime…
Daiwa's profit hits 13-year high as equities business surges
Daiwa Securities Group's latest quarterly profit rose more than analysts expected to the highest in 13 years, as Japan's second-largest brokerage benefited from a global stock trading boom. Net income rose 81% from a year earlier to ¥56.4…
AstraZeneca said to have explored Bristol Myers merger
AstraZeneca Plc has explored an acquisition of Bristol Myers Squibb Co., in a megadeal that would create one of the world's largest drugmakers, according to people familiar with the matter. The companies have held early-stage discussions about…
Banco BPM Pulls Out of Merger Talks With Monte Paschi
Italian bank Banco BPM said it dropped out of talks to merge with peer, in a move that could clear the way for a rival $35 billion takeover offer from Intesa Sanpaolo. BPM said Friday that conditions for reaching an agreement with Monte dei Paschi…
Barbeques Galore brand sold to Victorian wholesaler as chain closes
Sarah Thompson has co-edited Street Talk since 2009, specialising in private equity, investment banking, M&A and equity capital markets stories. Prior to that, she spent 10 years in London as a markets and M&A reporter at Bloomberg and Dow Jones.
Canva's summer slump sets off jitters among staff
Sarah Thompson has co-edited Street Talk since 2009, specialising in private equity, investment banking, M&A and equity capital markets stories. Prior to that, she spent 10 years in London as a markets and M&A reporter at Bloomberg and Dow Jones.
AMD neocloud OneQode rattles the tin with $250m-plus valuation
Local investors have seen their share of ASX-aspirants talking up Nvidia partnerships – Firmus Technologies, Sharon AI and Centuria-backed ResetData. Now, it's time to weigh the prospects of an AI business underpinned by the technology…
Inside M&S's Oxford Street swanky revamp, the blueprint for its £700m growth strategy
On a hot summer's evening on London's busy Oxford Street, a crowd of fashion influencers, models, journalists and the odd City analyst gathered for a first look at the upmarket revamp of Marks & Spencer's landmark Pantheon store. Some may have had…
Repligen: Acquisition To Add Cell Therapy Capabilities (NASDAQ:RGEN)
Repligen announced a $1.5B acquisition of BioLife Solutions to accelerate growth in the cell therapy market. Repligen delivered solid Q2 results, raising full-year guidance; organic growth reached 13% and adjusted EPS guidance is $2.06. Synergies…
Iress chairman Roger Sharp joins Potentia's Nitro Software
Seasoned director Roger Sharp is set to helm the board of fast-growing technology business Nitro Software in an appointment orchestrated by private equity owner Potentia Capital. Potentia acquired digital document software company Nitro three years…
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion
AstraZeneca Plc and Bristol Myers Squibb have reportedly held preliminary discussions about a potential merger that could create one of the world's largest pharmaceutical companies, with a combined market value approaching $400 billion. According…
According to media reports, AstraZeneca is exploring a mega-merger with Bristol Myers Squibb
Under CEO Pascal Soriot, AstraZeneca has become one of the world's leading manufacturers of cancer drugs in recent years. (File photo) According to media reports, the British pharmaceutical company AstraZeneca is considering a takeover of its U.S.
Dana White Reacts to MVP & PFL Merger
UFC president Dana White shared his reaction to the recent major industry announcement regarding the merger between MVP and PFL. This past week, Most Valuable Promotions (MVP) and the Professional Fighters League (PFL) announced that they are…
Receive a Daily briefing on M&A Industry News
Get Started